Study sheds light on the promising role of virtual reality in treating depression

FHS
May 6, 2024
4:55 pm

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 14, 2024

Bridging the gap in mental health services for pregnant women with serious mental illness

Women with serious mental illness (SMI) who are pregnant or planning a pregnancy face gaps in information, support and resources in mental health services, new

April 4, 2024

FDA clears Krystal Biotech’s IND for Type 1 AATD treatment KB408 – Pharmaceutical Technology

An artist illustration of a doctor holding lungs. The FDA granted orphan-drug status for KB408 in September for the treatment of serious lung disease caused

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.